Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
abbvie
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
merck
3
×
national
national blog main
national top stories
new york blog main
new york top stories
novartis
3
×
pfizer
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
albert bourla
alzheimer's disease
amgen
astrazeneca
cystic fibrosis
deals
diagnostics
drug prices
gilead sciences
What
drug
acquisitions
biggest
bio
ceo
roundup
today
albert
away
bourla
bringing
build
buy
ceos
company
company’s
crispr
daniel
dc
debut
dyne’s
executives
future
gathered
gilead
groups
hearing
held
imports
lower
maker
maps
measured
microbiome
moves
openly
o’day
patients
pfizer
pfizer’s
Language
unknown
unset
Current search:
merck
×
abbvie
×
photo
×
pfizer
×
novartis
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away